Mean plasmatic MIP-1β concentration (SI Figure S5) was not significantly increased in plasma from FD patients compared to healthy controls (13.08 ± 2.58 pg/mL in controls and 14.36 ± 22.99 pg/mL in FD patients: in naïve 11.14 ± 1.78 pg/mL and in ERT-treated 18.44 ± 37.91 pg/mL), and the obtained values were very close to the detection limit of the assay in most of the samples. Here, CCL4 is linked to Fabry disease.